Anxiety Disorders Terminated Phase 4 Trials for Sertraline (DB01104)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Terminated4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00182533Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood DisordersTreatment